Trexquant Investment’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.26M	Buy	293,305 +156,481	+114%	+$1.98M	0.02%	822
2025 Q4	$2.27M	Buy	136,824 +58,641	+75%	+$837K	0.02%	948
2025 Q3	$920K	Buy	+78,183	New	+$807K	0.01%	1176
2025 Q2	–	Sell	-398,751	Closed	-$2.5M	–	1797
2025 Q1	$2.5M	Buy	398,751 +20,114	+5%	+$122K	0.03%	788
2024 Q4	$3.07M	Buy	+378,637	New	+$4.69M	0.04%	699
2023 Q4	–	Sell	-58,825	Closed	-$610K	–	1708
2023 Q3	$610K	Buy	58,825 +40,524	+221%	+$556K	0.02%	933
2023 Q2	$262K	Buy	+18,301	New	+$211K	0.01%	1237
2022 Q4	–	Sell	-14,955	Closed	-$166K	–	1650
2022 Q3	$166K	Sell	14,955 -18,388	-55%	-$175K	0.01%	1230
2022 Q2	$281K	Buy	+33,343	New	+$343K	0.01%	1161
2021 Q1	–	Sell	-6,262	Closed	-$208K	–	1386
2020 Q4	$208K	Buy	+6,262	New	+$254K	0.02%	872